Equivalent price position
No other current listing with the same generic, strength, dosage form and compatible unit basis is available for comparison.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Rifampicin + Isoniazid + Pyrazinamide
- Therapeutic area
- Anti-infectives
- Drug class
- Antimycobacterials
- ATC
- J04AM
- Strength
- 120 mg + 50 mg + 300 mg
- Dosage form
- Tablet
- Pack
- 60’s
- Registration no.
- 009510
- Price record verified
- 2026-08-09
- Latest DRAP source check
- 2026-09-25 03:02
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
No change in the official DRAP price is recorded for this pack (60’s). Current price PKR 605.10, effective 1 Jul 2024.
Cite this price history
MedInfoBase. RIFATER 120 mg + 50 mg + 300 mg, 60’s: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/rifater-120-mg-50-mg-300-mg-009510-60s-pacific-pharmaceutical-ltd/ (accessed 25 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 605.10 | 2024-07-01 | 2026-09-22 | DRAP PharmaPrice Index (recovered from snapshot #84) | Current |
Other listed brands
Cite this record
Medicine record · DRAP registration 009510Price and registration data on this page were observed on 22 September 2026. Records change over time, so please cite the observation date alongside the access date.
